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Objective: There are no data available on gonococcal susceptibility
in the Caucasus region. We aimed to determine in vitro antimicrobial
susceptibility of Neisseria gonorrheae in Armenia in order to update
the national treatment protocol.
Methods: Isolates from men with urethral discharge presenting at 3
STI clinics in 3 different sites of Armenia were used to determine
susceptibility of N. gonorrheae strains for 11 antimicrobials using the
disc diffusion technique.
Results: Among the 101 isolates tested the susceptibility rate for
penicillin, doxycycline, and kanamycin were 37.6, 25.7, and 80.2%,
respectively. Sensitivity to quinolones was 95% for both oﬂoxacin and
ciproﬂoxacin. All strains were susceptible to third-generation cepha-
losporins and to spectinomycin. Only 11% of strains were susceptible
to all antibiotics tested.
Conclusion: Third-generation cephalosporines and spectinomycin
are suitable ﬁrst-line regimens. Quinolones are not advisable as ﬁrst-
line treatment given current borderline susceptibility, known tendency
for rapid resistance development in this class, and frequent over-the-
counter use of this antibiotic in Armenia.
ONE OF THE CONSEQUENCES of the collapse of the Soviet
Union, with its ensuing socioeconomic upheaval and widespread
collapse of the health care system, has been the alarming rise of
sexually transmitted infections in Eastern Europe and Central
Asia.1 STIs have become a major public health problem in this part
of the world2 and concern is further fuelled by the quickly spread-
ing HIV epidemic. In Armenia, as in other former Soviet Union
countries, poor health care seeking and underreporting are com-
mon with reported prevalence of STI being but the tip of the
iceberg.3 Furthermore, self-treatment is regular practice and anti-
biotics are easily available over the counter. Nevertheless, there
are indications that STIs are already widespread.4
Increasing antibiotic resistance of Neisseria gonorrheae is a
widespread problem. In much of the world, gonococci are already
resistant to penicillins and tetracyclines, and resistance to multiple
agents is common.5 Resistance of N. gonorrheae to ciproﬂoxacin
is also being detected and is spreading rapidly.6 While there is
some data from Russia and Kyrgyzstan showing high resistance to
a number of antimicrobials, there is still a paucity of resistance
data in the Commonwealth of Independent States (CIS).7–9 To
date, there is no data on gonococcal antimicrobial resistance in the
Caucasus, including Armenia.
This study was conducted to determine in vitro susceptibility of
N. gonorrheae in Armenia to update the national STI protocols for
gonorrhea treatment.
Methods
A multicenter study was carried out in 3 STI clinics located in
different sites of Armenia: the Medical-Scientiﬁc Center for Der-
matology and STI in the capital Yerevan; a STI clinic run by
Me ´decins sans frontie `res (MSF) in Gyumri, the second largest city;
and the MSF STI clinic in Bagratashen, a village located at the
Armenian-Georgian border and site of a large cross-border market.
Subjects included were all consecutive adult men presenting with
clinically conﬁrmed, simple acute urethritis. Patients with compli-
cated gonorrhea infection or antibiotic intake within the previous 3
weeks were excluded from the sample. All 3 clinics provided
anonymous and free-of-charge treatment for the patients. Ethical
approval was received by the Ethical Review Board of MSF and
written permission was obtained from the Ministry of Health of
Armenia.
The WHO recommendation of a minimum of 100 isolates was
used as a sample size estimate for the assessment of local patterns
of antibiotic resistance.5 Consecutive specimens were collected
between October 2003 and August 2004.
Immediate microscopic examination of Gram-stained urethral
specimens was followed by culture if Gram-negative intracellular
diplococci were identiﬁed. Selective modiﬁed Thayer-Martin me-
dium was used to isolate N. gonorrheae. Inoculated plates were
incubated for 24 to 48 hours in a CO2 enriched environment
(3–7%) at 35 to 37°C and 70% humidity. The presumptive iden-
tiﬁcation of N. gonorrheae was done with oxidase test, and posi-
tive cultures were transported at 25–40°C and in a CO2 enriched
atmosphere (Anaerocult  C mini, Merck) to the reference labora-
tory in Yerevan, where the presence of N. gonorrheae was con-
ﬁrmed by monoclonal phadebact GC technique. The nonselective
modiﬁed Thayer-Martin medium was used to subculture positive
colonies and for the sensitivity analyses. The susceptibility of N.
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686gonorrheae isolates was tested against 11 antibiotics using the disc
diffusion method (Neo-Sensitabs , Rosco, Denmark): azithromycin,
ceﬁxime, ceftriaxone, chloramphenicol, ciproﬂoxacin, doxycycline,
erythromycin, kanamycin, oﬂoxacin, penicillin, and spectinomycin.
Clinical and Laboratory Standards Institute (CLSI), former NCCLS,
susceptibility breakpoints were used for interpretation of inhibition
zone diameters when available, and azithromycin, chloramphenicol,
doxycycline, erythromycin, and kanamycin were interpreted using the
Rosco guidelines.10,11 Quality controls were performed using a gono-
coccal reference strain of known sensitivity (ATCC 49226, Becton
Dickinson).
Data were entered in Epi-info 6.04 days (CDC, Atlanta, GA),
and analysis was performed on Intercooled Stata 7.0 (Stata corpo-
ration, TX). Comparison between the percentages was made using
a 
2 test. For comparison of susceptibility patterns between study
sites, Fisher exact test was used.
Results
A total of 539 patients with acute urethral discharge was seen in
the study sites between October 2003 and August 2004; 407 of
them were eligible and consented for participation. On direct
microscopy Gram-negative diplococci were identiﬁed in 129 pa-
tients (31.7%): 28 of these were lost due to various reasons (most
commonly media contamination and transportation problems), and
the total number of sensitivity analyzes successfully performed
was 101. The approximate number of patients excluded from the
study, but later identiﬁed as having gonorrhea, was 6 and was
evenly distributed between the 3 sites.
Table 1 presents the susceptibility for the 11 antibiotics tested. The
lowest susceptibility was reported for penicillin and doxycycline. No
resistance to erythromycin, chloramphenicol, ceftriaxone, ceﬁxime,
and spectinomycin was found. Borderline susceptibility of 95% to
quinolones (ciproﬂoxacin, oﬂoxacin), recommended in the national
protocol as ﬁrst-line antibiotics for gonorrhea treatment, was reported.
There was decreased susceptibility to kanamycin as well.
Decreased susceptibility or resistance to more than 1 antimicro-
bials was detected in 90 (89.1%) of the strains. In addition, 58
(57.4%) strains showed decreased susceptibility to 2 and 3 anti-
microbials, the most common combination being penicillin and
doxycyclin. Most (4 out of 6) strains that had reduced susceptibil-
ity to quinolones also had reduced susceptibility to kanamycin,
penicillin, and doxycyclin. Only 11 (10.9%) strains were sensitive
to all 11 antibiotics tested.
Table 2 summarizes the distribution and the susceptibility char-
acteristics of the examined strains in 3 study sites. The suscepti-
bility of gonococcal strains was not signiﬁcantly different between
study sites (P 0.05).
Discussion
To our knowledge, this study was the ﬁrst in vitro sensitivity study
on N. gonorrheae carried out in Armenia and the Caucasus in general.
In the absence of comprehensive antimicrobial surveillance in the
TABLE 2. Susceptibility Distribution of N. gonorrhoeae Strains in Armenia by the Study Sites
Between October 2003 and August 2004
Penicillin Kanamacyn Doxycycline Oﬂoxacin Ciproﬂoxacin
Bagratashen (n  17)
Susceptible 8 (47.1) 14 (82.3) 4 (23.5) 16 (94.1) 16 (94.1)
Intermediate 8 (47.1) 2 (11.8) 13 (76.5) 0 (0.0) 0 (0.0)
Resistant 1 (5.8) 1 (5.9) 0 (0.0) 1 (5.9) 1 (5.9)
Gumri (n  24)
Susceptible 12 (50.0) 21 (87.5) 5 (20.8) 23 (95.8) 23 (95.8)
Intermediate 10 (41.7) 2 (8.3) 18 (75.0) 0 (0.0) 0 (0.0)
Resistant 2 (8.3) 1 (4.2) 1 (4.2) 1 (4.2) 1 (4.2)
Yerevan (n  60)
Susceptible 18 (30.0) 46 (76.7) 17 (28.3) 57 (95.0) 57 (95.0)
Intermediate 39 (65.0) 12 (20.0) 41 (68.3) 0 (0.0) 1 (1.7)
Resistant 3 (5.0) 2 (3.3) 2 (3.3) 3 (5.0) 2 (3.3)
TABLE 1. Susceptibility Results of 101 Strains of N. gonorrhoeae Isolated in Armenia Between
October 2003 and August 2004
Antibiotic (Disc Content in g)
Inhibition Zone
Diameter (mm)
Susceptible
n (%)
Intermediate
n (%)
Resistant
n (%) SIR
Azithromycin (30 g) 26 — 25 101 (100) 0 0
Ceﬁxime (30 g) 32 — — 101 (100) 0 0
Ceftriaxone (30 g) 32 — — 101 (100) 0 0
Chloramphenicol (60 g) 30 27–29 26 101 (100) 0 0
Ciproﬂoxacin (10 g) 36 30–35 29 96 (95.0) 1 (1.0) 4 (4.0)
Doxycycline (80 g) 36 27–35 26 26 (25.7) 72 (71.3) 3 (3.0)
Erythromycin (78 g) 30 — 29 101 (100) 0 0
Kanamycin (100 g) 28 24–27 23 81 (80.2) 16 (15.8) 4 (4.0)
Oﬂoxacin (10 g) 32 25–31 24 96 (95.0) 0 5 (5.0)
Penicillin G (5 g) 34 23–33 22 38 (37.6) 57 (56.4) 6 (5.9)
Spectinomycin (200 g) 23 20–22 19 101 (100) 0 0
Vol. 34 ● No. 9 687 ANTIMICROBIAL SUSCEPTIBILITY OF N. GONORRHEAE STRAINSformer Soviet Union, our data from Armenia contribute important
information to understanding the susceptibility patterns of gonorrhea
in this part of the World as during Soviet times treatment protocols
were the same throughout the entire Soviet Union.
Emerging resistance to quinolones (ciproﬂoxacin and oﬂoxacin)
in Armenia is evident, indicating that the WHO target of greater
than 95% efﬁcacy for drugs of the ﬁrst-line therapy is no longer
achievable for this class. Given the known tendency for rapid
resistance development in this quinolones class6 and frequent
over-the-counter sale of antibiotics in Armenia, further rapid in-
crease of resistance is a likely scenario. Higher resistance could
have been expected if men with previous antibiotic use or com-
plicated infection would have been included in the study as well.
This is clearly not the ﬁrst report of decreased quinolone suscep-
tibility in the former Soviet Union: ciproﬂoxacin susceptibility in
the Kyrgyzstan was 75%7 and decreased quinolone susceptibility
and occurrence of high-level resistance has been reported from
Russia.9,12,13
The high level of resistance to penicillin and tetracycline found
in our study is not surprising as this has been widely reported
throughout the world including Russia and Kyrgyzstan.7,9 Of note
is the decreased susceptibility for kanamycin, which was a ﬁrst-
line treatment option in the Armenian national protocol before this
study but has since been removed.
Armenia is a small country and the similar ﬁndings in the 3 sites
indicate that sites were comparable, and thus the results give a
good overview of the current situation in the country. However,
caution has to be exercised when extrapolating results to the entire
country as the study did not include patients from the south of the
country. Furthermore, the results could underestimate the real
trend of resistance as we excluded pretreated and complex cases of
gonorrhea infection.
We used the disc diffusion method to determine inhibitory zones,
as it is relatively cheap and easy to apply. The agar dilution for MIC,
which is the WHO reference method for resistance detection, can only
be performed in specialized laboratories and was not feasible in our
setting. Nevertheless, our results seem to be in accordance with the
current trends of resistance for N. gonorrheae. For susceptibility
testing, nonselective modiﬁed Thayer-Martin medium was used as it
was easier to obtain and it performed well when tested against the
CLSI recommended Quality Control strain N. gonorrheae ATCC
49226. The Neo-sensitabs disks, which were considered as antimi-
crobials of choice in our setting, as they can be kept at room temper-
ature, complied with Q.C zone diameters, recommended for tests on
gonococcus agar when tested against N. gonorrheae ATCC 49226 on
modiﬁed Thayer-Martin.11
The proportion of penicillin resistance due to the -lactamase
production is not known as due to the technical problems the
-lactamase testing was discontinued. Another limitation of the
current study was the use of only 1 control strain. Nalidixic acid
could have been tested to ensure that resistance to all quinolones is
detected. However, it should be kept in mind that the study was
conducted in a developing country where susceptibility testing is
not done on a routine basis.
The lack of resistance to third-generation cephalosporines (ce-
ﬁxime and ceftriaxone) in our study make these drugs excellent
choices as ﬁrst-line treatment in Armenia. Spectinomycin, an antibi-
otic almost exclusively used for the treatment of gonorrhea and no
detected resistance in our study is a good ﬁrst-line choice too.
Following the recommendations from this study, ceﬁxime was
included as an alternative ﬁrst-line treatment in the Armenian
national protocol. This was also warranted because resistance to
ciproﬂoxacin is approaching 5%, and lack of resources in Armenia
will make regular surveillance unlikely. At present, due to cheaper
price, ciproﬂoxacin remained ﬁrst-line treatment for simple gono-
coccal infections, and spectinomycin was not included as ﬁrst-line
due to price. Future studies to assess the resistance trends in
Armenia and to allow timely revision of treatment protocols are
highly recommended, and donors should be encouraged to fund
such studies.
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